Acumen Pharmaceuticals Inc (ABOS) — Financial Flexibility Index
Acumen Pharmaceuticals Inc (ABOS) has a Financial Flexibility Index of -0.36x as of December 2025. Free cash flow of $-19.10 Million (operating CF $-19.10 Million minus capex $0.00) represents 0% of total liabilities ($52.40 Million). Also explore ABOS net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acumen Pharmaceuticals Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Acumen Pharmaceuticals Inc across 7 annual periods. Check ABOS strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Acumen Pharmaceuticals Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Acumen Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Acumen Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-115.45 Million | $-115.54 Million | $52.40 Million | ▼ -46.1% |
| 2024 | -1.51x | $-86.20 Million | $-86.22 Million | $57.18 Million | ▼ -51.1% |
| 2023 | -1.00x | $-43.04 Million | $-43.06 Million | $43.15 Million | ▲ +77.7% |
| 2022 | -4.48x | $-34.99 Million | $-35.15 Million | $7.81 Million | ▼ -28.6% |
| 2021 | -3.48x | $-17.92 Million | $-17.96 Million | $5.15 Million | ▼ -2861.2% |
| 2020 | -0.12x | $-7.41 Million | $-7.45 Million | $63.02 Million | ▲ +67.5% |
| 2019 | -0.36x | $-6.78 Million | $-6.82 Million | $18.74 Million | — |